Steven L. Basta
Chief Executive Officer, BIOFORM MEDICAL INC.
Companies
- Phathom Pharmaceuticals, Inc.Board member Apr 3, 2025 to now1
- Phathom Pharmaceuticals, Inc.Chief executive officer Apr 3, 2025 to now1
- Phathom Pharmaceuticals, Inc.President Apr 3, 2025 to now1
- Yarrow Bioscience, Inc.Board member Jan 24, 2018 to now2
- VIVEVE MEDICAL, INC.Board member Sep 13, 2018 to Jan 5, 20233
- Yarrow Bioscience, Inc.Chief executive officer Jan 24, 2018 to Dec 16, 20192
- Yarrow Bioscience, Inc.Officer Jul 31, 2019 to Jul 31, 20194
- KalVista Pharmaceuticals, Inc.Board member Apr 8, 2015 to Nov 22, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Phathom Pharmaceuticals, Inc. PHAT373,315 shares6$2.6M at $7.03Feb 10, 2026
- VIVEVE MEDICAL, INC.25 shares7Dec 15, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 10, 2026Shares withheld for tax 6,277 shares at $12.82 of Phathom Pharmaceuticals, Inc.6
- Feb 10, 2026Granted 12,362 shares of Phathom Pharmaceuticals, Inc.6
- Jan 2, 2026Granted 251,034 shares of Phathom Pharmaceuticals, Inc.8
- Dec 17, 2025Shares withheld for tax 31,502 shares at $15.36 of Phathom Pharmaceuticals, Inc.9
- Dec 17, 2025Granted 62,038 shares of Phathom Pharmaceuticals, Inc.9
- Nov 28, 2025Shares withheld for tax 48,375 shares at $15.62 of Phathom Pharmaceuticals, Inc.10
- Nov 28, 2025Exercised options 90,000 shares of Phathom Pharmaceuticals, Inc.10
- Sep 25, 2025Shares withheld for tax 48,375 shares at $11.66 of Phathom Pharmaceuticals, Inc.11
- Sep 25, 2025Exercised options 90,000 shares of Phathom Pharmaceuticals, Inc.11
- Dec 15, 2021Returned to company 28 shares at $1.41 of VIVEVE MEDICAL, INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARVIVEVE MEDICAL, INC., Board member
- 4SEC EDGARYarrow Bioscience, Inc., Officer
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jan 2, 2026
- 9SEC EDGARForm 4 filed Dec 19, 2025
- 10SEC EDGARForm 4 filed Dec 2, 2025
- 11SEC EDGARForm 4 filed Sep 26, 2025